GlaxoSmithKline PLC (
) will begin trading ex-dividend on May 14, 2014. A cash dividend
payment of $0.640034 per share is scheduled to be paid on July 10,
2014. Shareholders who purchased GSK stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
-14.62% decrease from the prior quarter. At the current stock price
of $55.14, the dividend yield is 4.64%.
The previous trading day's last sale of GSK was $55.14,
representing a -2.8% decrease from the 52 week high of $56.73 and a
14.16% increase over the 52 week low of $48.30.
GSK is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Novartis AG (
). GSK's current earnings per share, an indicator of a company's
profitability, is $3.39. Zacks Investment Research reports GSK's
forecasted earnings growth in 2014 as 2.68%, compared to an
industry average of 1.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to GSK through an Exchange
Traded Fund [ETF]?
The following ETF(s) have GSK as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- FlexShares International Quality Dividend Defensive Index
- FlexShares International Quality Dividend Index Fund (
- FlexShares Morningstar Developed Markets ex-US Factor Tilt
The top-performing ETF of this group is PPH with an increase of
15.47% over the last 100 days. It also has the highest percent
weighting of GSK at 5%.